{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:16:36Z","timestamp":1785417396787,"version":"3.56.0"},"reference-count":52,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P 35262-B"],"award-info":[{"award-number":["P 35262-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"award":["P 35262-B"],"award-info":[{"award-number":["P 35262-B"]}],"id":[{"id":"https:\/\/ror.org\/013tf3c58","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Age-related osteoporosis is characterized by progressive loss of bone mass and deterioration of bone microarchitecture, leading to enhanced skeletal fragility. Cytokines regulate bone remodeling through distinct signaling pathways. Baricitinib, a selective JAK1\/2 inhibitor effective in inflammatory disorders such as rheumatoid arthritis, suppresses cytokine signaling, but its role in age-related osteoporosis remains insufficiently defined. In our study a total of 60 eight-month-old female SAMP8 mice were randomized to receive baricitinib (10 mg\/kg) or vehicle twice daily by oral gavage for six weeks. Bone outcomes were evaluated by high-resolution micro-computed tomography (\u00b5CT) and static histomorphometry. Intracellular cytokine production by splenocytes was determined via flow cytometry. We found that baricitinib substantially reduced T-cell cytokine production, decreasing IL-6, IL-17, IFN-\u03b3, and IL-21 in CD4+ T cells and IL-6 in CD8+ T cells, accompanied by lower IFN-\u03b3\/IL-17 and IL-21\/IL-6 ratios, respectively. \u00b5CT analyses showed no significant intergroup differences in BV\/TV, whereas histomorphometry demonstrated higher BV\/TV in the baricitinib group. Overall, baricitinib was found to effectively suppressed proinflammatory cytokines in aged SAMP8 mice but did not consistently enhance bone parameters, indicating reduced skeletal responsiveness during aging.<\/jats:p>","DOI":"10.3390\/ijms27115047","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:33:14Z","timestamp":1780479194000},"page":"5047","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging"],"prefix":"10.3390","volume":"27","author":[{"given":"Katharina","family":"Gelles","sequence":"first","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Kurz","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Butylina","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wahl-Figlash","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7017-5426","authenticated-orcid":false,"given":"Martin","family":"Schepelmann","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-9546","authenticated-orcid":false,"given":"Anastasia","family":"Meshcheryakova","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Comprehensive Center for AI in Medicine (CAIM), Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-2892","authenticated-orcid":false,"given":"Peter","family":"Pietschmann","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility Fractures in Europe: Burden, Management and Opportunities","volume":"15","author":"Karlsson","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"New Horizons in Osteoporosis","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000166209","article-title":"Osteoporosis: An Age-Related and Gender-Specific Disease\u2014A Mini-Review","volume":"55","author":"Pietschmann","year":"2009","journal-title":"Gerontology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chandra, A., and Rajawat, J. (2021). Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073553"},{"key":"ref_5","first-page":"1017","article-title":"Osteoporosis: Pathophysiology and Therapeutic Options","volume":"19","author":"Dovjak","year":"2020","journal-title":"EXCLI J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1159\/000546107","article-title":"Animal Models for Age-Related Osteoporosis","volume":"71","author":"Gelles","year":"2025","journal-title":"Gerontology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-Term and Sequential Treatment for Osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"F\u00f6ger-Samwald, U., Kerschan-Schindl, K., Butylina, M., and Pietschmann, P. (2022). Age Related Osteoporosis: Targeting Cellular Senescence. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052701"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Srivastava, R.K., Dar, H.Y., and Mishra, P.K. (2018). Immunoporosis: Immunology of Osteoporosis\u2014Role of T Cells. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00657"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000098223","article-title":"Osteoimmunology","volume":"143","author":"Rauner","year":"2007","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.abb.2010.05.027","article-title":"The Immune System and Bone","volume":"503","author":"Pacifici","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: Shared Mechanisms and Crosstalk between the Immune and Bone Systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s41232-023-00293-3","article-title":"Effect of JAK Inhibitors on the Three Forms of Bone Damage in Autoimmune Arthritis: Joint Erosion, Periarticular Osteopenia, and Systemic Bone Loss","volume":"43","author":"Komagamine","year":"2023","journal-title":"Inflamm. Regen."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eaay4447","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK Inhibition Increases Bone Mass in Steady-State Conditions and Ameliorates Pathological Bone Loss by Stimulating Osteoblast Function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2016.10.001","article-title":"Targeting Cytokine Signaling in Autoimmunity: Back to the Future and Beyond","volume":"43","author":"Hirahara","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK Inhibitor Selectivity: New Opportunities, Better Drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e23930","DOI":"10.4161\/jkst.23930","article-title":"JAK-STAT and Bone Metabolism","volume":"2","author":"Li","year":"2013","journal-title":"JAK-STAT"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shawky, A.M., Almalki, F.A., Abdalla, A.N., Abdelazeem, A.H., and Gouda, A.M. (2022). A Comprehensive Overview of Globally Approved JAK Inhibitors. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051001"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK\u2013STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40259-013-0040-7","article-title":"The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders","volume":"27","author":"Furumoto","year":"2013","journal-title":"BioDrugs"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Collotta, D., Franchina, M.P., Carlucci, V., and Collino, M. (2023). Recent Advances in JAK Inhibitors for the Treatment of Metabolic Syndrome. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1245535"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.42617","article-title":"Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial","volume":"75","author":"Simon","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/annrheumdis-2014-206478","article-title":"Safety and Efficacy of Baricitinib at 24 Weeks in Patients with Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate","volume":"74","author":"Keystone","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Murakami, K., Kobayashi, Y., Uehara, S., Suzuki, T., Koide, M., Yamashita, T., Nakamura, M., Takahashi, N., Kato, H., and Udagawa, N. (2017). A Jak1\/2 Inhibitor, Baricitinib, Inhibits Osteoclastogenesis by Suppressing RANKL Expression in Osteoblasts in Vitro. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181126"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00223-025-01410-9","article-title":"Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study","volume":"116","author":"Schulz","year":"2025","journal-title":"Calcif. Tissue Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2017.07.008","article-title":"An Animal Model of Co-Existing Sarcopenia and Osteoporotic Fracture in Senescence Accelerated Mouse Prone 8 (SAMP8)","volume":"97","author":"Zhang","year":"2017","journal-title":"Exp. Gerontol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1538\/expanim.15-0025","article-title":"Muscle Mass, Structural and Functional Investigations of Senescence-Accelerated Mouse P8 (SAMP8)","volume":"64","author":"Leung","year":"2015","journal-title":"Exp. Anim."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aitella, E., Azzellino, G., Romano, C., Ginaldi, L., and De Martinis, M. (2025). Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199268"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: An Evolutionary Perspective on Immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116540","DOI":"10.1016\/j.bone.2022.116540","article-title":"Cytokine-Mediated Immunomodulation of Osteoclastogenesis","volume":"164","author":"Zhou","year":"2022","journal-title":"Bone"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study","volume":"93","author":"Ding","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/ar2297","article-title":"IL-23 Induces Human Osteoclastogenesis via IL-17 in Vitro, and Anti-IL-23 Antibody Attenuates Collagen-Induced Arthritis in Rats","volume":"9","author":"Yago","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-3083.2006.01795.x","article-title":"Interleukin-21 Induces T-cell Activation and Proinflammatory Cytokine Secretion in Rheumatoid Arthritis","volume":"64","author":"Li","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0531-5565(90)90067-C","article-title":"The Role of Interleukin-1 in Postmenopausal Bone Loss","volume":"25","author":"Pacifici","year":"1990","journal-title":"Exp. Gerontol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000443531","article-title":"Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women","volume":"68","author":"Zhao","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2008.02.017","article-title":"Estrogen Deficiency Increases Osteoclastogenesis Up-Regulating T Cells Activity: A Key Mechanism in Osteoporosis","volume":"43","author":"Grimaldi","year":"2008","journal-title":"Bone"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1038\/s41598-025-94894-2","article-title":"Comparison of Anti-Inflammatory and Anti-Angiogenic Effects of JAK Inhibitors in IL-6 and TNF\u03b1-Stimulated Fibroblast-like Synoviocytes Derived from Patients","volume":"15","author":"Suda","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"106549","DOI":"10.1016\/j.intimp.2020.106549","article-title":"Chronotherapy Targeting Cytokine Secretion Attenuates Collagen-Induced Arthritis in Mice","volume":"84","author":"Yaekura","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib Restrains the Immune Dysregulation in Patients with Severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jinf.2021.02.023","article-title":"In-Vitro Evaluation of the Immunomodulatory Effects of Baricitinib: Implication for COVID-19 Therapy","volume":"82","author":"Petrone","year":"2021","journal-title":"J. Infect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13287-025-04874-6","article-title":"Senescence of Bone Marrow Mesenchymal Stromal Cells: A Narrative Review of Mechanisms, Functional Consequences, and Rejuvenation Strategies for Age-Related Disorders","volume":"17","author":"Zhang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of Bone Turnover for the Prediction of Fracture Risk and Monitoring of Osteoporosis Treatment: A Need for International Reference Standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","article-title":"International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on Bone Marker Standards in Osteoporosis","volume":"49","author":"Vasikaran","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Guo, X., Yu, X., Yao, Q., and Qin, J. (2022). Early Effects of Ovariectomy on Bone Microstructure, Bone Turnover Markers and Mechanical Properties in Rats. BMC Musculoskelet. Disord., 23.","DOI":"10.1186\/s12891-022-05265-1"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00198-021-05871-0","article-title":"Effects of One-Year Tofacitinib Therapy on Bone Metabolism in Rheumatoid Arthritis","volume":"32","author":"Hamar","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0531-5565(03)00189-X","article-title":"The Effect of Age and Gender on Cytokine Production by Human Peripheral Blood Mononuclear Cells and Markers of Bone Metabolism","volume":"38","author":"Pietschmann","year":"2003","journal-title":"Exp. Gerontol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bone.2014.04.022","article-title":"Cathepsin S Controls Adipocytic and Osteoblastic Differentiation, Bone Turnover, and Bone Microarchitecture","volume":"64","author":"Rauner","year":"2014","journal-title":"Bone"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for Assessment of Bone Microstructure in Rodents Using Micro\u2013Computed Tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5047\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:35:16Z","timestamp":1780479316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27115047"],"URL":"https:\/\/doi.org\/10.3390\/ijms27115047","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}